6 Results for "

pf+0732

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "pf+0732" in MCE Product Catalog:

111
111 Cited Publications
Cat. No.: HY-138687
CAS No.: 2628280-40-8
Purity:  99.74%
Synonyms: PF-07321332
Target:  

SARS-CoV

Research Areas:  

Infection Inflammation/Immunology

Nirmatrelvir (PF-07321332) is a potent and orally active SARS-CoV 3C-like protease (3CL PRO) inhibitor. Nirmatrelvir (PF-07321332) targets to the SARS-CoV-2 virus and can be used for COVID-19 research .
loading...
    loading...
Cat. No.: HY-159648
CAS No.: 2936625-34-0
Target:  

Endogenous Metabolite

Research Areas:  

Cardiovascular Disease

PF-07328948 is an orally effective BDK (branch chain ketoacid dehydrogenase kinase) inhibitor, with IC50 of 110 nM. PF-07328948 acts as a BCKDH (branch chain ketoacid dehydrogenase) enzyme complex degrader to enhance BCAA (branch chain amino acid) catabolism. PF-07328948 improves metabolic and heart failure end points in rats .
loading...
    loading...
Cat. No.: HY-138687S
CAS No.: 2861202-76-6
Purity:  99.93%
Synonyms: PF-07321332-d9
Nirmatrelvir-d9 (PF-07321332-d9) is the deuterium labeled Nirmatrelvir (HY-138687) .
loading...
    loading...
Cat. No.: HY-138687R
CAS No.: 2628280-40-8
Synonyms: PF-07321332 (Standard)
Nirmatrelvir (Standard) is the analytical standard of Nirmatrelvir. This product is intended for research and analytical applications. Nirmatrelvir (PF-07321332) is a potent and orally active SARS-CoV 3C-like protease (3CL PRO) inhibitor. Nirmatrelvir (PF-07321332) targets to the SARS-CoV-2 virus and can be used for COVID-19 research .
loading...
    loading...
Cat. No.: HY-P991635

Target:  

TNF Receptor

Research Areas:  

Cancer

PF-07329640 is a humanized monoclonal antibody inhibitor targeting TNFRSF3. PF-07329640 can be used for advanced/metastatic solid tumors like non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) research .
loading...
    loading...
Cat. No.: HY-138687S1
CAS No.: 2861202-75-5
Synonyms: PF-07321332-d6
Nirmatrelvir-d6 (PF-07321332-d6) is deuterium labeled Nirmatrelvir. Nirmatrelvir (PF-07321332) is a potent and orally active SARS-CoV 3C-like protease (3CL PRO) inhibitor. Nirmatrelvir (PF-07321332) targets to the SARS-CoV-2 virus and can be used for COVID-19 research .
loading...
    loading...